美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70518-4662-0	70518-4662	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20260518	N/A	ANDA	ANDA201893	REMEDYREPACK INC.	NADOLOL	40 mg/1	50 POUCH in 1 BOX (70518-4662-0) / 1 TABLET in 1 POUCH (70518-4662-1)
59651-589-01	59651-589	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20220607	N/A	ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	20 mg/1	100 TABLET in 1 BOTTLE (59651-589-01)
68001-691-00	68001-691	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20260330	N/A	ANDA	ANDA201893	BluePoint Laboratories	NADOLOL	40 mg/1	100 TABLET in 1 BOTTLE (68001-691-00)
68001-690-00	68001-690	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20260317	N/A	ANDA	ANDA201893	BluePoint Laboratories	NADOLOL	20 mg/1	100 TABLET in 1 BOTTLE (68001-690-00)
68001-692-00	68001-692	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20260225	N/A	ANDA	ANDA201893	BluePoint Laboratories	NADOLOL	80 mg/1	100 TABLET in 1 BOTTLE (68001-692-00)
59651-252-01	59651-252	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20211029	N/A	ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	80 mg/1	100 TABLET in 1 BOTTLE (59651-252-01)
59651-251-01	59651-251	HUMAN PRESCRIPTION DRUG	Nadolol	Nadolol	TABLET	ORAL	20211029	N/A	ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	40 mg/1	100 TABLET in 1 BOTTLE (59651-251-01)